Latest Funds News

Page 1 of 1667
OpenLearning has increased its placement to $930,000 while trimming the maximum entitlement offer to $1.99 million after 30 million placement shares moved beyond the record date. The revised structure would leave ECA with 55.92% after the placement, or 61.33% if it takes up its full entitlement and other shareholders do not participate.
Victor Sage
Victor Sage
17 Nov 2026
Li-FT Power has reported broad, high-grade lithium intersections from the underexplored Galinée Zone at its Adina project in Québec, led by 45 metres at 2.71% Li₂O. The results will feed into a combined resource estimate and preliminary economic assessment targeted for early 2027.
Maxwell Dee
Maxwell Dee
17 Nov 2026
MA Credit Income Trust has opened a voluntary off-market buy-back for up to 1.25% of its units, giving eligible investors another way to exit at the trust’s net asset value. The final price will be set on 31 December, while acceptances may be scaled back or rejected at the responsible entity’s discretion.
Claire Turing
Claire Turing
17 Nov 2026
Ashley Services lifted revenue sharply in the first four months of FY27 as its new logistics labour hire acquisition outperformed expectations. But weaker underlying demand, a training slump, higher funding costs and a $4 million PALM-related revenue hit have complicated the growth story.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Jameson Resources has moved Crown Mountain into the final stage of British Columbia’s environmental assessment process, with an Environmental Certificate targeted for the first half of 2027. The proposed steelmaking coal mine still depends on regulatory approval, Indigenous partnership agreements, project funding and a final investment decision.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026
Finbar has completed the $7.5 million acquisition of a 5,317-square-metre Ascot site, where it is targeting more than 200 apartments and 500 square metres of commercial space. The proposed project carries an estimated end value of $166 million, but its final yield, design and approvals are still to be determined.
Victor Sage
Victor Sage
17 Nov 2026
Corazon Mining is evaluating a build-own-operate carbon-in-leach plant at its Chalice Gold Project, with an initial 600,000-tonne annual capacity and expansion potential to 1.8 million tonnes. The proposal could reduce upfront processing capital, but remains non-binding and depends on metallurgy, approvals, funding and a definitive contract.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Actinogen Medical’s shares have been suspended while it completes analysis of additional data from its pivotal XanaMIA Alzheimer’s trial. The company expects trading to resume no later than 19 November unless the results announcement comes first.
Ada Torres
Ada Torres
17 Nov 2026
Island Pharmaceuticals is moving Galidesivir into a decisive sequence of Marburg animal studies after the FDA confirmed an Animal Rule pathway for the antiviral. The company also expects to generate prospective human data through an approved Uganda Ebola program, although approval, funding and commercial outcomes remain unresolved.
Victor Sage
Victor Sage
17 Nov 2026
Microba Life Sciences has been suspended from trading after revised terms for its proposed Genetic Signatures merger left it unable to complete the second tranche of its institutional placement. The company says it is assessing alternative funding while its cashflow runway narrows.
Victor Sage
Victor Sage
17 Nov 2026
Metgasco has opened a five-for-one renounceable entitlement offer targeting up to A$2.02 million, with one free attaching option for every new share issued. Up to A$1 million of the raising is underwritten, but any GSC-backed shortfall may reduce debt rather than deliver cash to the company.
Victor Sage
Victor Sage
17 Nov 2026

Browse the archive

Full archive